<?xml version="1.0" encoding="UTF-8"?>
<p id="Par7">Mesenchymal stem cells (MSC) derived from bone marrow, adipose, or other sources can exert inhibitory effects on immune-mediated disease states [
 <xref ref-type="bibr" rid="CR6">6</xref>–
 <xref ref-type="bibr" rid="CR10">10</xref>]. In particular, MSC derived from umbilical cord (UC) Wharton's Jelly possess a high proliferative and expansive ability, an enhanced therapeutic activity compared to other MSC [
 <xref ref-type="bibr" rid="CR11">11</xref>–
 <xref ref-type="bibr" rid="CR14">14</xref>], and superior production of growth factors that stimulate secretions responsible for therapeutic potential [
 <xref ref-type="bibr" rid="CR15">15</xref>].
</p>
